Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Eur Respir J
.
2020 Feb 27;55(2):2000048.
doi: 10.1183/13993003.00048-2020.
Print 2020 Feb.
Authors
Duncan Keeley
1
,
Jane E Scullion
2
,
Omar S Usmani
3
Affiliations
1
Thame, UK.
2
University Hospitals of Leicester NHS Trust, Leicester, UK.
3
National Heart and Lung Institute, Imperial College London, London, UK o.usmani@imperial.ac.uk.
PMID:
32108081
DOI:
10.1183/13993003.00048-2020
No abstract available
Publication types
Editorial
MeSH terms
Administration, Inhalation
Bronchodilator Agents
Carbon*
Environment
Humans
Metered Dose Inhalers
Nebulizers and Vaporizers*
Policy
Substances
Bronchodilator Agents
Carbon